1 active not recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Active not recruiting 1 |
Follow Interstitial Lung Diseases: new trials by email Literature Review of Interstitial Lung Diseases trials Research Report on Interstitial Lung Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Anlotinib Capsules in the Treatment for IPF/PF-ILDs Anlotinib, Placebo - Interstitial Lung Diseases | Phase 2 | Active not recruiting | First Affiliated Hospital of Wenzhou Medical University | 30 | 2021-09-28 | 2026-06-05 |
Idiopathic Pulmonary Fibrosis (1) · Lung Diseases, Interstitial (1)
Lung Diseases (1) · Pulmonary Fibrosis (1) · Respiratory Tract Diseases (1)
anlotinib (1)
First Affiliated Hospital of Wenzhou Medical University (1)
China (1)